155 related articles for article (PubMed ID: 29656007)
1. miR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer.
Yu X; Zhang Y; Ma X; Pertsemlidis A
Cancer Lett; 2018 Jul; 427():85-93. PubMed ID: 29656007
[TBL] [Abstract][Full Text] [Related]
2. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
3. miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).
Ye J; Zhang Z; Sun L; Fang Y; Xu X; Zhou G
Mol Biosyst; 2016 Oct; 12(11):3417-3424. PubMed ID: 27714074
[TBL] [Abstract][Full Text] [Related]
4. MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.
Liu B; Qu J; Xu F; Guo Y; Wang Y; Yu H; Qian B
Oncotarget; 2015 Apr; 6(11):9445-56. PubMed ID: 25840419
[TBL] [Abstract][Full Text] [Related]
5. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y
Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-1204 promotes cell proliferation by regulating PITX1 in non-small-cell lung cancer.
Jiang W; He Y; Shi Y; Guo Z; Yang S; Wei K; Pan C; Xia Y; Chen Y
Cell Biol Int; 2019 Mar; 43(3):253-264. PubMed ID: 30549141
[TBL] [Abstract][Full Text] [Related]
7. miR-19a contributes to gefitinib resistance and epithelial mesenchymal transition in non-small cell lung cancer cells by targeting c-Met.
Cao X; Lai S; Hu F; Li G; Wang G; Luo X; Fu X; Hu J
Sci Rep; 2017 Jun; 7(1):2939. PubMed ID: 28592790
[TBL] [Abstract][Full Text] [Related]
8. MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer.
Li B; Ren S; Li X; Wang Y; Garfield D; Zhou S; Chen X; Su C; Chen M; Kuang P; Gao G; He Y; Fan L; Fei K; Zhou C; Schmit-Bindert G
Lung Cancer; 2014 Feb; 83(2):146-53. PubMed ID: 24331411
[TBL] [Abstract][Full Text] [Related]
9. miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor.
Qin Q; Wei F; Zhang J; Wang X; Li B
J Cell Mol Med; 2016 Oct; 20(10):1974-83. PubMed ID: 27241841
[TBL] [Abstract][Full Text] [Related]
10. MiroRNA-188 Acts as Tumor Suppressor in Non-Small-Cell Lung Cancer by Targeting MAP3K3.
Zhao L; Ni X; Zhao L; Zhang Y; Jin D; Yin W; Wang D; Zhang W
Mol Pharm; 2018 Apr; 15(4):1682-1689. PubMed ID: 29528232
[TBL] [Abstract][Full Text] [Related]
11. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
12. The miR-195 Axis Regulates Chemoresistance through TUBB and Lung Cancer Progression through BIRC5.
Yu X; Zhang Y; Wu B; Kurie JM; Pertsemlidis A
Mol Ther Oncolytics; 2019 Sep; 14():288-298. PubMed ID: 31508486
[TBL] [Abstract][Full Text] [Related]
13. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1.
Gan CZ; Li G; Luo QS; Li HM
IUBMB Life; 2017 Nov; 69(11):841-849. PubMed ID: 28940895
[TBL] [Abstract][Full Text] [Related]
14. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.
Zhang H; Hu B; Wang Z; Zhang F; Wei H; Li L
Cancer Chemother Pharmacol; 2017 Nov; 80(5):973-984. PubMed ID: 28956120
[TBL] [Abstract][Full Text] [Related]
15. MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN.
Xue X; Liu Y; Wang Y; Meng M; Wang K; Zang X; Zhao S; Sun X; Cui L; Pan L; Liu S
Oncotarget; 2016 Dec; 7(51):84508-84519. PubMed ID: 27811366
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
Yang T; Chen T; Li Y; Gao L; Zhang S; Wang T; Chen M
Tumour Biol; 2015 Mar; 36(3):1903-11. PubMed ID: 25432132
[TBL] [Abstract][Full Text] [Related]
17. miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC.
Wang X; Meng Q; Qiao W; Ma R; Ju W; Hu J; Lu H; Cui J; Jin Z; Zhao Y; Wang Y
Stem Cell Res Ther; 2018 Nov; 9(1):327. PubMed ID: 30470250
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-4443 promotes the resistance of non-small cell lung cancer cells to epirubicin by targeting INPP4A and regulating the activation of JAK2/STAT3 pathway.
Zhang W; Qiao B; Fan J
Pharmazie; 2018 Jul; 73(7):386-392. PubMed ID: 30001772
[TBL] [Abstract][Full Text] [Related]
19. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
20. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
